| 000 | 01699 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516063302.0 | ||
| 264 | 0 | _c20130117 | |
| 008 | 201301s 0 0 eng d | ||
| 022 | _a1435-5604 | ||
| 024 | 7 |
_a10.1007/s00774-011-0331-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMaines, Evelina | |
| 245 | 0 | 0 |
_aChildren and adolescents treated with neridronate for osteogenesis imperfecta show no evidence of any osteonecrosis of the jaw. _h[electronic resource] |
| 260 |
_bJournal of bone and mineral metabolism _cJul 2012 |
||
| 300 |
_a434-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBisphosphonate-Associated Osteonecrosis of the Jaw _xepidemiology |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xadministration & dosage |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aDiphosphonates _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 |
_aItaly _xepidemiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOsteogenesis Imperfecta _xdrug therapy |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aMonti, Elena | |
| 700 | 1 | _aDoro, Francesco | |
| 700 | 1 | _aMorandi, Grazia | |
| 700 | 1 | _aCavarzere, Paolo | |
| 700 | 1 | _aAntoniazzi, Franco | |
| 773 | 0 |
_tJournal of bone and mineral metabolism _gvol. 30 _gno. 4 _gp. 434-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00774-011-0331-3 _zAvailable from publisher's website |
| 999 |
_c21294692 _d21294692 |
||